Kazia Therapeutics (KZIA) Prepaid Assets (2009 - 2016)
Kazia Therapeutics (KZIA) posted Prepaid Assets of $1.9 million for Q4 2016, up 240.24% on a QoQ basis from $566061.7 in Q2 2016.
Kazia Therapeutics (KZIA) has 5 years of Prepaid Assets data on file, last reported at $1.9 million in Q4 2016.
- In Q4 2016, Prepaid Assets changed N/A year-over-year to $1.9 million; the TTM figure through Dec 2016 stood at $1.9 million (changed N/A YoY), while the FY2016 annual figure was $552487.6, changed N/A from the prior year.
- Prepaid Assets rose to $1.9 million in Q4 2016, from $566061.7 in the prior quarter.
- Across five years, Prepaid Assets topped out at $1.9 million in Q4 2016 and bottomed at $208169.9 in Q2 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 1.93 Mn |
| Jun 30, 2016 | 566,061.66 |
| Jun 30, 2012 | 208,169.94 |
| Dec 31, 2011 | 273,994.61 |
| Jun 30, 2011 | 553,137.23 |
| Dec 31, 2010 | 343,687.42 |
| Jun 30, 2010 | 390,744.04 |
| Dec 31, 2009 | 444,477.57 |
| Jun 30, 2009 | 428,805.14 |